Development of novel IL-6R/IL-6 interaction inhibitors for severe COVID-19 pneumonia treatment

○Yukio Takamori

[27P01-054S] Development of novel IL-6R/IL-6 interaction inhibitors for severe COVID-19 pneumonia treatment

○Yukio Takamori¹, Takehiro Ando¹, Daisuke Fuji², Mizuki Yamamoto¹, Takashi Kawakami^3,4 (1. Integr. Grad. Sch. Med. Eng. Agr. Sci., Yamanashi Univ., 2. Fac. Life Environ. Sci., Yamanashi Univ., 3. Grad. Fac. Interdiscip. Res, Yamanashi Univ., 4. JST PRESTO)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[27P01] ケミカルバイオロジー

[27P01-054S] Development of novel IL-6R/IL-6 interaction inhibitors for severe COVID-19 pneumonia treatment

Password